Phillip Angart Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II U.S. Food and Drug Administration Biography Publications Institution JoVE Articles Phillip Angart has not added a biography. If you are Phillip Angart and would like to personalize this page please email our Author Liaison for assistance. Publications Purification et analyse d'un anticorps monoclonal à partir de cellules ovaires de hamster chinois à l'aide d'un système automatisé de microbioréacteur Sai Rashmika Velugula-Yellela1, David N. Powers1, Phillip Angart1, Anneliese Faustino1, Talia Faison1, Casey Kohnhorst1, Erica J. Fratz-Berilla1, Cyrus D. Agarabi1 1Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, U.S. Food and Drug Administration JoVE 58947 Bioengineering Utilisation du haut débit MICROBIOREACTEUR système automatisé pour la Production d’IgG1 de modèle dans les cellules CHO Sai Rashmika Velugula-Yellela1, Casey Kohnhorst1, David N. Powers1, Nicholas Trunfio1, Anneliese Faustino1, Phillip Angart1, Erica Berilla1, Talia Faison1, Cyrus Agarabi1 1Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, U.S. Food and Drug Administration JoVE 58231 Bioengineering
Purification et analyse d'un anticorps monoclonal à partir de cellules ovaires de hamster chinois à l'aide d'un système automatisé de microbioréacteur Sai Rashmika Velugula-Yellela1, David N. Powers1, Phillip Angart1, Anneliese Faustino1, Talia Faison1, Casey Kohnhorst1, Erica J. Fratz-Berilla1, Cyrus D. Agarabi1 1Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, U.S. Food and Drug Administration JoVE 58947 Bioengineering
Utilisation du haut débit MICROBIOREACTEUR système automatisé pour la Production d’IgG1 de modèle dans les cellules CHO Sai Rashmika Velugula-Yellela1, Casey Kohnhorst1, David N. Powers1, Nicholas Trunfio1, Anneliese Faustino1, Phillip Angart1, Erica Berilla1, Talia Faison1, Cyrus Agarabi1 1Center for Drug Evaluation and Research, Office of Product Quality, Office of Biotechnology Products, Division of Biotechnology Review and Research II, U.S. Food and Drug Administration JoVE 58231 Bioengineering
